Snake venom is a rich source of bioactive molecules that hold great promise for therapeutic
applications. These molecules can be broadly classified into enzymes and non-enzymes …

Toxicofera reptile venoms are composed of several toxins, including serine proteases.
These proteases are glycosylated enzymes that affect the prey's hemostatic system. Their …

Because of the high incidence of Pseudomonas aeruginosa biofilms-related nosocomial
infections, venoms from common Thai snakes were tested. Although venoms from king …

Background Inflammation and platelet activation play pivotal roles in acute ischemic stroke
(AIS) pathogenesis. Early response to thrombolysis is a vital indicator for the long-term …

Advances in medical nanobiotechnology have notably enhanced the application of snake
venom toxins, facilitating the development of new therapies with animal-derived toxins. The …

Viperidae snakes are the most important agents of snakebites in Brazil. The protein
composition of snake venoms has been frequently analyzed by means of electrophoretic …

Aims To analyze intensive slow mannitol poststenting on attenuating stenting‐related early
adverse effects in cerebral venous sinus stenosis (CVSS). Methods This real‐world study …

Snake venoms, comprising a complex array of protein-rich components, an important part of
which are snake venom metalloproteinases (SVMPs). These SVMPs, which are …

Ischemic cerebrovascular disease (ICD), the most common neurological disease worldwide,
can be classified based on the onset time (acute/chronic) and the type of cerebral blood …

Aims The objective of this study was to evaluate the effectiveness of batroxobin in improving
functional outcomes and reducing stroke recurrence among patients with acute ischemic …